Works in any phone browserNo appNo installFree to start
Ask a Dermatologist

Topical Steroid Creams: A Dermatologist's Safe-Use Guide

Hydrocortisone, betamethasone, clobetasol — same drug class, vastly different strengths. Here's the safe-use framework.

April 2026AUBy Dr. Anand S. UrhekarEvidence-based
Share

Get an instant AI skin check

Our AI analyzes skin concerns using clinical criteria in seconds.

BlogAsk a Dermatologist

MD Dermatology · 25+ yrs international practice

Dermatologist's quick take

  • Topical steroids are graded by potency (mild → super-potent), not by 'strength of the bottle'
  • Mild (hydrocortisone 1%) is OTC; mid- to super-potent need prescription
  • Use the weakest effective strength for the shortest time on the smallest area
  • Skin atrophy, telangiectasia, and steroid acne signal overuse
  • Topical steroid withdrawal is real but rare — taper, don't stop abruptly after months of use

I'm Dr. Urhekar. Topical steroids are some of the most useful and most misused drugs in dermatology. Used correctly, they end weeks of inflammation in days. Used incorrectly — wrong strength, wrong site, too long — they cause skin thinning, rosacea-like reactions, infections, and dependence.

This guide gives you the dermatologist framework. Crucially, before you treat anything with steroids, identify what you're treating — many "eczema" cases are actually fungal, allergic, or rosacea, all of which steroids worsen. Use a free AI skin analysis at ScanSkinAI to triage first.

Potency hierarchy (UK/US classification)

Mild (Class VII)

Hydrocortisone 0.5–2.5%. OTC. Face, eyelids, groin, paediatric use, mild eczema.

Moderate (Class IV–VI)

Clobetasone, triamcinolone 0.025%. Mild-moderate eczema, body, short courses.

Potent (Class II–III)

Betamethasone 0.1%, mometasone. Active eczema flares, psoriasis on body.

Super-potent (Class I)

Clobetasol 0.05%. Specialist use only. Maximum 2-week courses on body, never on face.

Treatment duration

Mild: up to 2 weeks. Potent: 1 week + taper. Maintenance: 2x weekly weekend therapy.

Site adjustments

Face/genitals: weakest only. Palms/soles: stronger needed due to thick skin.

How to apply correctly — the FTU rule

The fingertip unit (FTU) is the line of cream from the tip of an adult index finger to the first crease. One FTU treats an area equal to two adult palms.

  • Face and neck: 2.5 FTU
  • One arm: 3 FTU
  • One leg: 6 FTU
  • Whole front of trunk: 7 FTU
  • Whole back: 7 FTU

Apply twice daily during a flare; reduce to once daily as inflammation subsides.

Common side effects (and how to avoid them)

Reducing steroid side effects

  • Use the weakest effective strength for shortest time on smallest area
  • Switch to weekend-only maintenance once flare resolves
  • Combine with daily emollient/moisturiser to reduce steroid quantity needed
  • Rotate to non-steroidal calcineurin inhibitors (tacrolimus) for sensitive sites
  • Re-evaluate diagnosis every 4 weeks if not improving
  • Photograph the area weekly to track progress objectively

Skin atrophy

Long-term potent steroid use thins the dermis and epidermis, causing fragile, transparent skin with visible blood vessels (telangiectasia) and easy bruising. Most common on face, eyelids, and inner thighs. Reversible only partially — take this seriously.

Steroid-induced rosacea / perioral dermatitis

Persistent redness around the mouth, nose, or eyes after weeks of facial steroid use. Worsens every time you stop ("rebound"). Treat by stopping the steroid (gradual taper if needed) plus oral tetracycline antibiotics, prescribed by a dermatologist.

Topical steroid withdrawal (TSW)

Severe burning, redness, shedding and weeping after stopping prolonged moderate-to-potent steroid use. More common with use on the face, eyelids, or genitals for 12+ months. Recovery can take 6–24 months. Prevention is taper, not abrupt stop.

See a dermatologist before continuing if:

  • Steroid cream not improving the rash after 7–10 days
  • Rash is spreading despite treatment (consider fungal or allergic cause)
  • Persistent redness around mouth or eyes after steroid use
  • Visible thinning, stretch marks, or telangiectasia from previous use
  • Symptoms returning each time you stop, requiring near-constant use
  • Use on a child <2 years for more than 7 days

Alternatives to steroids

For long-term inflammatory skin disease, modern alternatives reduce reliance on steroids:

  • Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — no skin atrophy, safe for face/genitals
  • PDE-4 inhibitors (crisaborole, roflumilast) — newer, well tolerated
  • JAK inhibitors (ruxolitinib cream) — for moderate eczema and vitiligo
  • Biologics (dupilumab, tralokinumab) — severe eczema requiring systemic therapy

Bottom line

Topical steroids are excellent tools when matched correctly to condition, site, and duration. Use them as a sprint, not a marathon. Identify what you're treating — the difference between eczema, fungal infection, and rosacea matters enormously. See eczema vs dry skin and rosacea signs & triggers for differentiation.

Identify the condition first

Free AI skin check helps distinguish eczema, dermatitis, fungal and other rashes before you treat.

Free AI Skin Check

Frequently Asked Questions

Dr. Anand S. Urhekar

Verified

MD Dermatology · 25+ yrs · Section Head, M.P. Shah Hospital Nairobi · Former UN Dermatologist

Dr. Urhekar is a board-certified dermatologist with over 25 years of practice across Africa, the Middle East and Asia. As Section Head of Dermatology at M.P. Shah Hospital Nairobi and a former UN dermatologist, he specialises in tropical skin disease, Fitzpatrick IV–VI skin care and global health.

International · APAC · Africa · Middle EastGeneral dermatology, tropical conditions, skin of colour
Meet our full clinical team

Sources

  1. Moles: OverviewAmerican Academy of Dermatology (2024)
  2. Skin TagsAmerican Academy of Dermatology (2024)
  3. MolesNHS UK (2024)
  4. MolesMayo Clinic (2024)

Dr. Anand S. Urhekar

Verified

MD Dermatology · 25+ yrs · Section Head, M.P. Shah Hospital Nairobi · Former UN Dermatologist

Dr. Urhekar is a board-certified dermatologist with over 25 years of practice across Africa, the Middle East and Asia. As Section Head of Dermatology at M.P. Shah Hospital Nairobi and a former UN dermatologist, he specialises in tropical skin disease, Fitzpatrick IV–VI skin care and global health.

International · APAC · Africa · Middle EastGeneral dermatology, tropical conditions, skin of colour
Meet our full clinical team

Medical Disclaimer: This article is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions about a skin condition. If you think you may have a medical emergency, call your doctor or emergency services immediately.